Search
Patidegib
go.drugbank.com/drugs/DB12655InvestigationalPatidegib has been investigated for the treatment of Conventional Chondrosarcoma.
BMS-582949
go.drugbank.com/drugs/DB12696InvestigationalBMS-582949 has been investigated for the treatment of Psoriasis.
PH-797804
go.drugbank.com/drugs/DB07941InvestigationalPH-797804 has been investigated for the treatment of Osteoarthritis.
Integrin alpha-5
go.drugbank.com/bio_entities/BE0008988TargetHumansITGA5:ITGB1 is a receptor for IL1B and binding is essential for IL1B signaling (PubMed:29030430). … ITGA5:ITGB3 is a receptor for soluble CD40LG and is required for CD40/CD40LG signaling (PubMed:31331973).
Synonyms: Fibronectin receptor subunit alphaEphrin-B2
go.drugbank.com/bio_entities/BE0010647TargetHumansBinds to receptor tyrosine kinase including EPHA4, EPHA3 and EPHB4. … The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling.
Synonyms: EPH-related receptor tyrosine kinase ligand 5Function: ephrin receptor bindingEtizolam
go.drugbank.com/drugs/DB09166InvestigationalIt is not approved for use by FDA in the US; however it remains unscheduled in several states and is legal for research purposes. … Initially introduced in 1983 in Japan as treatment for neurological conditions such as anxiety and sleep disorders, etizolam is marketed in Japan, Italy and India.
XL019
go.drugbank.com/drugs/DB05243InvestigationalAn IND for XL019 was filed by Exelixis in May 2007.
SPP1148
go.drugbank.com/drugs/DB05203ExperimentalSPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.
PF-4191834
go.drugbank.com/drugs/DB11645InvestigationalPF-4191834 has been investigated for the basic science of Asthma.
Brivanib alaninate
go.drugbank.com/drugs/DB11865InvestigationalBrivanib alaninate has been investigated for the treatment of Colorectal Cancer.